Elon Musk Says He Prefers Lilly’s Mounjaro over Novo’s Ozempic

Seeking Alpha2024-12-27

An X post from Elon Musk on Wednesday highlighted Tesla (TSLA) CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product Ozempic.Known ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Aivern
2024-12-27
Aivern
Dude is a pseudo engineer who runs his workers into the ground to optimize the assembly line and everyone thinks he knows everything about everything. Ffs simp humans.

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113204099?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-27 11:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113204099","market":"us","top_or_hot":-1,"title":"Elon Musk Says He Prefers Lilly’s Mounjaro over Novo’s Ozempic","media":"Seeking Alpha","content":"<div>\n<p>An X post from Elon Musk on Wednesday highlighted Tesla (TSLA) CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product Ozempic.Known ...</p>\n\n<a href=\"https://seekingalpha.com/news/4390958-elon-musk-prefers-lilly-mounjaro-over-novo-ozempic\">Source Link</a>\n\n</div>\n","source":"lsy1728464409321","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk Says He Prefers Lilly’s Mounjaro over Novo’s Ozempic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk Says He Prefers Lilly’s Mounjaro over Novo’s Ozempic\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-27 11:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4390958-elon-musk-prefers-lilly-mounjaro-over-novo-ozempic><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>An X post from Elon Musk on Wednesday highlighted Tesla (TSLA) CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product Ozempic.Known ...</p>\n\n<a href=\"https://seekingalpha.com/news/4390958-elon-musk-prefers-lilly-mounjaro-over-novo-ozempic\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO","symbol_name":"诺和诺德","start_time":0,"source_url":"https://seekingalpha.com/news/4390958-elon-musk-prefers-lilly-mounjaro-over-novo-ozempic","article_id":"1113204099","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113204099","pubTimestamp":1735270961,"columns":[],"sourceInfo":{"source_id":"lsy1728464409321","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"An X post from Elon Musk on Wednesday highlighted Tesla  CEO's newfound preference for Eli Lilly's  weight loss therapy Mounjaro over Novo Nordisk's  rival product Ozempic.Known as tirzepatide and semaglutide in generic terms, Mounjaro and Ozempic belong to a new class of diabetes drugs called GLP-1s, marketed as Zepbound and Wegovy for weight loss, respectively.\"Like Cocaine Bear, but Santa and Ozempic!\" Musk said, dressed as Santa Claus in a post titled \"Ozempic Santa.\"In response to a questio","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVO":"诺和诺德","LLY":"礼来"},"translate_title":"埃隆·马斯克表示，与Novo的Ozempic相比，他更喜欢礼来公司的Mounjaro","themeId":"10ac66c99b6823819ede208a9746f099","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":1.1,"NVO":1.1},"content_text":"An X post from Elon Musk on Wednesday highlighted Tesla (TSLA) CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product Ozempic.Known as tirzepatide and semaglutide in generic terms, Mounjaro and Ozempic belong to a new class of diabetes drugs called GLP-1s, marketed as Zepbound and Wegovy for weight loss, respectively.\"Like Cocaine Bear, but Santa and Ozempic!\" Musk said, dressed as Santa Claus in a post titled \"Ozempic Santa.\"In response to a question on the specific product he uses, Musk, who also heads the space exploration company SpaceX (SPACE), noted, \"Technically, Mounjaro, but that doesn't have the same ring to it.\"\"Mounjaro seems to have fewer side effects and be more effective,\" he explained. In 2022, Musk, the incoming co-chair of President-elect Donald Trump's newly created Department of Government Efficiency, credited Wegovy for his weight loss.Given his unwavering support for GLP-1s, Musk seems to be at odds with Trump's pick for health secretary, Robert F. Kennedy Jr., who has long advocated for dietary control over drugs to fight America's obesity epidemic.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":386000499642848,"gmtCreate":1735279047145,"gmtModify":1735279051363,"author":{"id":"4097767435236930","authorId":"4097767435236930","name":"Aivern","avatar":"https://static.tigerbbs.com/3827d6c7271c872fcc616eaa9b4f7f54","vip":1,"crmLevel":4,"crmLevelSwitch":1,"idStr":"4097767435236930","authorIdStr":"4097767435236930"},"htmlText":"Dude is a pseudo engineer who runs his workers into the ground to optimize the assembly line and everyone thinks he knows everything about everything. Ffs simp humans.","listText":"Dude is a pseudo engineer who runs his workers into the ground to optimize the assembly line and everyone thinks he knows everything about everything. Ffs simp humans.","text":"Dude is a pseudo engineer who runs his workers into the ground to optimize the assembly line and everyone thinks he knows everything about everything. Ffs simp humans.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/386000499642848","repostId":1113204099,"repostType":2,"repost":{"id":"1113204099","kind":"news","pubTimestamp":1735270961,"share":"https://ttm.financial/m/news/1113204099?lang=&edition=fundamental","pubTime":"2024-12-27 11:42","market":"us","language":"en","title":"Elon Musk Says He Prefers Lilly’s Mounjaro over Novo’s Ozempic","url":"https://stock-news.laohu8.com/highlight/detail?id=1113204099","media":"Seeking Alpha","summary":"An X post from Elon Musk on Wednesday highlighted Tesla  CEO's newfound preference for Eli Lilly's  weight loss therapy Mounjaro over Novo Nordisk's  rival product Ozempic.Known as tirzepatide and semaglutide in generic terms, Mounjaro and Ozempic belong to a new class of diabetes drugs called GLP-1s, marketed as Zepbound and Wegovy for weight loss, respectively.\"Like Cocaine Bear, but Santa and Ozempic!\" Musk said, dressed as Santa Claus in a post titled \"Ozempic Santa.\"In response to a questio","content":"<html><head></head><body><p>An X post from Elon Musk on Wednesday highlighted Tesla (TSLA) CEO&#39;s newfound preference for Eli Lilly&#39;s (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk&#39;s (NVO) rival product Ozempic.</p><p style=\"text-align: left;\">Known as tirzepatide and semaglutide in generic terms, Mounjaro and Ozempic belong to a new class of diabetes drugs called GLP-1s, marketed as Zepbound and Wegovy for weight loss, respectively.</p><p style=\"text-align: left;\">&#34;Like Cocaine Bear, but Santa and Ozempic!&#34; Musk said, dressed as Santa Claus in a post titled &#34;Ozempic Santa.&#34;</p><p style=\"text-align: left;\">In response to a question on the specific product he uses, Musk, who also heads the space exploration company SpaceX (SPACE), noted, &#34;Technically, Mounjaro, but that doesn&#39;t have the same ring to it.&#34;</p><p style=\"text-align: left;\">&#34;Mounjaro seems to have fewer side effects and be more effective,&#34; he explained. In 2022, Musk, the incoming co-chair of President-elect Donald Trump&#39;s newly created Department of Government Efficiency, credited Wegovy for his weight loss.</p><p style=\"text-align: left;\">Given his unwavering support for GLP-1s, Musk seems to be at odds with Trump&#39;s pick for health secretary, Robert F. Kennedy Jr., who has long advocated for dietary control over drugs to fight America&#39;s obesity epidemic.</p></body></html>","source":"lsy1728464409321","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk Says He Prefers Lilly’s Mounjaro over Novo’s Ozempic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk Says He Prefers Lilly’s Mounjaro over Novo’s Ozempic\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-27 11:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4390958-elon-musk-prefers-lilly-mounjaro-over-novo-ozempic><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>An X post from Elon Musk on Wednesday highlighted Tesla (TSLA) CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product Ozempic.Known ...</p>\n\n<a href=\"https://seekingalpha.com/news/4390958-elon-musk-prefers-lilly-mounjaro-over-novo-ozempic\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVO":"诺和诺德","LLY":"礼来"},"source_url":"https://seekingalpha.com/news/4390958-elon-musk-prefers-lilly-mounjaro-over-novo-ozempic","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113204099","content_text":"An X post from Elon Musk on Wednesday highlighted Tesla (TSLA) CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product Ozempic.Known as tirzepatide and semaglutide in generic terms, Mounjaro and Ozempic belong to a new class of diabetes drugs called GLP-1s, marketed as Zepbound and Wegovy for weight loss, respectively.\"Like Cocaine Bear, but Santa and Ozempic!\" Musk said, dressed as Santa Claus in a post titled \"Ozempic Santa.\"In response to a question on the specific product he uses, Musk, who also heads the space exploration company SpaceX (SPACE), noted, \"Technically, Mounjaro, but that doesn't have the same ring to it.\"\"Mounjaro seems to have fewer side effects and be more effective,\" he explained. In 2022, Musk, the incoming co-chair of President-elect Donald Trump's newly created Department of Government Efficiency, credited Wegovy for his weight loss.Given his unwavering support for GLP-1s, Musk seems to be at odds with Trump's pick for health secretary, Robert F. Kennedy Jr., who has long advocated for dietary control over drugs to fight America's obesity epidemic.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":13,"commentSize":1,"repostSize":1,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113204099"}